Quarter results
AbbVie Raises Profit Expectations Despite Q2 Decrease in Humira and Imbruvica Sales
SG Tylor
AbbVie executives express satisfaction with the introduction of Humira biosimilars in the US, despite facing significant revenue declines for both ...
